NEW YORK (GenomeWeb News) – AltheaDx today announced that it has been named an Affymetrix authorized service provider.
 
The San Diego-based molecular testing services provider said that the deal enables it to offer biomarker discovery and development services based on Affy’s GeneChip microarray platform. It said it would use the genotyping and gene expression platform to identify new biomarkers and analyze gene pathways that are critical to the development and progression of cancer.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.